Registration number:
AB UK Medical Ltd
for the Period from 29 March 2023 to 26 March 2024
AB UK Medical Ltd
(Registration number: 09373419)
Balance Sheet as at 26 March 2024
Note |
2024 |
2023 |
|
Fixed assets |
|||
Tangible assets |
- |
|
|
Current assets |
|||
Debtors |
- |
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
( |
|
Net current liabilities |
( |
( |
|
Total assets less current liabilities |
( |
( |
|
Creditors: Amounts falling due after more than one year |
( |
( |
|
Provisions for liabilities |
( |
( |
|
Net liabilities |
( |
( |
|
Capital and reserves |
|||
Called up share capital |
2 |
2 |
|
Retained earnings |
(64,162) |
(63,923) |
|
Shareholders' deficit |
(64,160) |
(63,921) |
For the financial period ending 26 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
• |
|
• |
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
Approved and authorised by the
......................................... |
AB UK Medical Ltd
Notes to the Financial Statements for the Period from 29 March 2023 to 26 March 2024
General information |
The company is a private company limited by share capital, incorporated in England and wales.
The address of its registered office is:
These financial statements were authorised for issue by the
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Going concern
At the balance sheet date the company had net liabilities of £64,160 (£63,921). The director consider it appropriate to prepare the financial statements on the going concern basis, despite the technical insolvency of the company.
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
Asset class |
Depreciation method and rate |
Furniture, fittings and equipment |
33.33% straight line (Fully written-off) |
Staff numbers |
The average number of persons employed by the company (including the director) during the period, was
AB UK Medical Ltd
Notes to the Financial Statements for the Period from 29 March 2023 to 26 March 2024
Tangible assets |
Furniture, fittings and equipment |
Total |
|
Cost or valuation |
||
At 29 March 2023 |
|
|
At 26 March 2024 |
|
|
Depreciation |
||
At 29 March 2023 |
|
|
Charge for the period |
|
|
At 26 March 2024 |
|
|
Carrying amount |
||
At 26 March 2024 |
- |
- |
At 28 March 2023 |
|
|
Debtors |
Current |
2024 |
2023 |
Other debtors |
- |
|
- |
|
Creditors |
Creditors: amounts falling due within one year
Note |
2024 |
2023 |
|
Due within one year |
|||
Trade creditors |
|
|
|
Other creditors |
|
|
|
|
|
||
Due after one year |
|||
Loans and borrowings |
|
|